2-es típusú cukorbetegség: vizsgálatok itt: Kína
189 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleQUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 820
- Run by
- Huijie Zhang
See details and how to joinNCT07775846 - 2. fázisNot yet taking people in KínaFuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Therapy
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 150
- Run by
- Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07929350 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Beijing, Changchun, Hefei, Herbin, Huizhou, Jinan, Langfang, Luoyang, Nanjing, Pingxiang, Shanghai, Suzhou, Xianyang, Zhenjiang
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Beijing, Cangzhou, Changchun, Hefei, Herbin, Huizhou, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Ningbo, Pingxiang, Shanghai, Siping, Suzhou, Wuxi, Xi'an, Xianyang, Xuzhou, Yueyang, Zhenjiang
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
- Where
- Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi, Jincheng, Jinzhou Shi, Langfang, Luoyang, Meihekou, Nanjing, Nanyang, Shanghai, Shantou, Shenyang, Shijiazhuang, Wuhan, Wuhu, Xianyang, Xuzhou, Yan’an, Yueyang, Zhumadian, Zibo
- Életkor
- 18 év and over
- People
- 351 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07775404 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisNot yet taking people in KínaEfficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
- Where
- Nanjing, Shanghai
- Életkor
- 18 év and over
- People
- 450
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07920939 - 3. fázisNot yet taking people in KínaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- Where
- Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07922330 - 2. fázisNot yet taking people in KínaA Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 364
- Run by
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
See details and how to joinNCT07923357 - No phaseTaking peopleChiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes
- Where
- Beijing, Chengdu
- Életkor
- 18 év to 75 év
- People
- 3550
- Run by
- Chipscreen Biosciences, Ltd.
See details and how to joinNCT07580638 - 3. fázisTaking peopleA Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
- Where
- Beijing, Changchun, Hefei, Herbin, Huai'an, Huzhou, Jinan, Langfang, Luoyang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Xianyang, Zhengzhou, Zibo
- Életkor
- 18 év and over
- People
- 300
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07670416 - 2. fázisNot yet taking people in KínaFuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 150
- Run by
- Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07920640 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Beijing, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai, Tianjin, Zigong
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Hefei, Huzhou, Jinan, Luoyang Shi, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Wenzhou, Wuhan, Xianyang
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 4. fázisTaking peopleAI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
- Where
- Chongqing, Hefei, Taiyuan, Wenzhou
- Életkor
- 18 év to 65 év
- People
- 285
- Run by
- The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07697391 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Changchun, Jinan, Luoyang Shi, Nanjing, Ningbo, Shijiazhuang, Tianjin
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 3. fázisNot yet taking people in KínaA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Luoyang, Luzhou, Nanchang, Nanjing, Nanyang, Ningbo, Qinhuangdao Shi, Shanghai, Shijiazhuang, Suzhou, Xianyang
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 3. fázisNot yet taking people in KínaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Liaoyou, Luoyang Shi, Nanjing, Shanghai, Shijiazhuang, Tianjin, Wenzhou, Xuzhou, Yibin, Zigong
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisNot yet taking people in KínaA Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin
- Where
- Shanghai, Shenzhen
- Életkor
- 18 év and over
- People
- 680
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07913061 - 1/2. fázisNot yet taking people in KínacfMSC Therapy for Diabetes
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT07495956 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Chenzhou, Chifeng, Hangzhou, Hefei, Huai'an, Jinan, Jincheng, Jining, Jinzhou Shi, Kaifeng, Langfang, Liangyugang, Luoyang, Meihekou, Nanjing, Nantong, Nanyang, Pinggu, Pingxiang, Sanya, Shanghai, Shantou, Shenyang, Shijiazhuang, Tianjin, Wuhan, Wuhu, Xi'an, Xiangyang, Xianyang, Xuzhou, Yan’an, Yueyang, Zhumadian, Zibo
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleAcupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 60
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07907536 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Huizhou, Jiangmen, Jinan, Jining, Jinzhou, Lanzhou, Lishui, Luoyang, Macau, Nanchang, Nanjing, Nanning, Nantong, Nanyang, Ningbo, Pingxiang, Qinhuangdao, Shanghai, Shenyang, Siping, Suzhou, Tianjin, Wenzhou, Wuhan, Xiamen, Xi'an, Xiangyang, Xianyang, Xuancheng, Xuzhou, Yinchuan, Zhenjiang, Zibo
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Beijing, Cangzhou, Changchun, Chengdu, Danyang, Ganzhou, Guangzhou, Huizhou, Huzhou, Lanzhou, Nanjing, Panjin, Suzhou, Xianyang
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270